Clinical trial
Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate…
NCT00154635 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00154635 |
|---|---|
| Title | Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease |
| Official title | A Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease |
| Lead sponsor | National Taiwan University Hospital, Other |
| Collaborators | Development Center for Biotechnology, Taiwan Taipei Veterans General Hospital, Taiwan Program Office, National Science & Technology, Biotechnology & Pharmaceuticals |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Dementia, Alzheimer Type |
| Intervention type | Drug |
| Interventions | DCB-AD1 |
| Enrollment | 80 |
| Start date | Sep 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 12, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: